6-ethyl-2-methyl-2,3-dihydro-1H-inden-1-one | 343856-58-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 6-ethyl-2-methyl-2,3-dihydro-1H-inden-1-one
• 英文别名: 6-Ethyl-2-methyl-2,3-dihydroinden-1-one
• CAS: 343856-58-6
• 化学式: C₁₂H₁₄O
• 分子量: 174.243
• InChiKey: JJARVPPFJKHTKJ-UHFFFAOYSA-N

物化性质

• 沸点：
  285.2±25.0 °C(Predicted)
• 密度：
  1.038±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  6-ethyl-2-methyl-2,3-dihydro-1H-inden-1-one 在 硫酸 、 溶剂黄146 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 8.5h， 生成 ethyl 2-(5-ethyl-2-methyl-1H-inden-3-yl)acetate
  参考文献：
  名称：

  Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation

  摘要：

  RXR alpha represents an intriguing and unique target for pharmacologic interventions. We recently showed that Sulindac and a designed analog could bind to RXR alpha and modulate its biological activity, including inhibition of the interaction of an N-terminally truncated RXR alpha (tRXR alpha) with the p85 alpha regulatory subunit of phosphatidylinositol-3-OH kinase (PI3K). Here we report the synthesis, testing and SAR of a series of novel analogs of Sulindac as potential modulators for inhibiting tRXR alpha-dependent AKT activation. A new compound 30 was identified to have improved biological activity. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.01.012
• 作为产物：
  描述：

  4-乙基苯甲醛 在 palladium 10% on activated carbon 、 氢气 、 potassium carbonate 作用下， 以 甲醇 为溶剂， 180.0 ℃ 、1.01 MPa 条件下， 反应 48.08h， 生成 6-ethyl-2-methyl-2,3-dihydro-1H-inden-1-one
  参考文献：
  名称：

  Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation

  摘要：

  RXR alpha represents an intriguing and unique target for pharmacologic interventions. We recently showed that Sulindac and a designed analog could bind to RXR alpha and modulate its biological activity, including inhibition of the interaction of an N-terminally truncated RXR alpha (tRXR alpha) with the p85 alpha regulatory subunit of phosphatidylinositol-3-OH kinase (PI3K). Here we report the synthesis, testing and SAR of a series of novel analogs of Sulindac as potential modulators for inhibiting tRXR alpha-dependent AKT activation. A new compound 30 was identified to have improved biological activity. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.01.012

文献信息

• ORGANIC COMPOUNDS
  申请人：Givaudan SA

  公开号：US20200330346A1

  公开（公告）日：2020-10-22

  The present invention refers to indanone derivatives of formula (I) wherein R 1 is selected from hydrogen, methyl and ethyl; R 2 is selected from hydrogen, methyl and ethyl, and R 3 is selected from hydrogen and methyl; or R 2 and R 3 form together with the carbon atoms to which they are attached C 3 -C 5 cycloalkyl; and R 4 is selected from C 2 -C 5 alkyl, C 2 -C 5 alkenyl, C 1 -C 4 alkoxy, C 3 -C 5 cycloalkyl, and C 3 -C 6 cycloalkenyl. The invention further refers to perfume compositions and fragrance applications comprising them.

  本发明涉及式(I)的吲哚酮衍生物，其中R1选择氢、甲基和乙基；R2选择氢、甲基和乙基，R3选择氢和甲基；或R2和R3与它们附着的碳原子一起形成C3-C5环烷基；R4选择C2-C5烷基、C2-C5烯基、C1-C4烷氧基、C3-C5环烷基和C3-C6环烯基。该发明还涉及包含它们的香水组合物和香料应用。
• Process for the Preparation of Idnanones
  申请人：GIVAUDAN SA

  公开号：US20190263743A1

  公开（公告）日：2019-08-29

  A process of forming compounds of formula I comprising the steps of addition of an amino compound H 2 NR to a compound of formula (II) followed by cyclization, isomerization and hydrolysis.

  将公式I的化合物形成的过程包括将氨基化合物H2NR加入到公式（II）的化合物中，然后进行环化、异构化和水解。
• Organic compounds
  申请人：Givaudan SA

  公开号：US11020333B2

  公开（公告）日：2021-06-01

  The present invention refers to indanone derivatives of formula (I) wherein R1 is selected from hydrogen, methyl and ethyl; R2 is selected from hydrogen, methyl and ethyl, and R is selected from hydrogen and methyl; or R2 and R3 form together with the carbon atoms to which they are attached C3-C5 cycloalkyl; and R4 is selected from C2-C5 alkyl, C2-C5 alkenyl, C1-C4 alkoxy, C3-C5 cycloalkyl, and C3-C6 cycloalkenyl. The invention further refers to perfume compositions and fragrance applications comprising them.

  本发明涉及式 (I) 的茚酮衍生物 在其中 R1 选自氢、甲基和乙基 R2 选自氢、甲基和乙基，R 选自氢和甲基；或 R2 和 R3 与它们所连接的碳原子一起形成 C3-C5 环烷基；以及 R4 选自 C2-C5 烷基、C2-C5 烯基、C1-C4 烷氧基、C3-C5 环烷基和 C3-C6 环烯基。 本发明还涉及香水组合物和包含它们的香料应用。
• PINNICK, H. W.;BROWN, S. P.;MCLEAN, E. A.;ZOLLER, L. W. ,, III, J. ORG. CHEM., 1981, 46, N 18, 3758-3760
  作者：PINNICK, H. W.、BROWN, S. P.、MCLEAN, E. A.、ZOLLER, L. W. ,, III

  DOI：——

  日期：——
• PROCESS FOR THE PREPARATION OF INDANONES
  申请人：Givaudan SA

  公开号：EP3497078A2

  公开（公告）日：2019-06-19